DoD Lupus, Transformative Vision Award | W81XWH 21 LRP TVA

Opportunity Information: Apply for W81XWH 21 LRP TVA

The Department of Defense (DoD) Lupus Research Program (LRP) Transformative Vision Award (TVA) is a discretionary research funding opportunity designed to support unusually bold, high-impact projects that can noticeably improve the day-to-day quality of life for people living with lupus in the near term. The central expectation is not simply to generate new knowledge, but to translate research ideas into a practical, testable intervention that can be implemented at the level of the individual patient and/or within the healthcare system. Projects can target lupus patients of any age and may focus on quality-of-life challenges broadly, including issues affecting groups that carry disproportionate health burdens.

A defining feature of this award is its emphasis on clear, meaningful impact. Applicants are expected to describe, in direct and concrete terms, how their proposed intervention would change outcomes that matter to patients and families, and why those changes would be significant. The TVA is framed as high-risk, high-reward, meaning the program is open to ambitious approaches as long as they are backed by a credible rationale and a realistic plan for testing and achieving the stated vision. Preliminary data are required, which signals that the DoD wants applicants to show early evidence that the approach is feasible and worth scaling into a larger translational effort.

From a scientific standpoint, the research strategy must show a strong grasp of lupus and the underlying problems the intervention is meant to address. Reviewers will be looking for thoughtful justification, careful methodology, and an experimental plan that reflects an in-depth understanding of the disease and the real-world context of lupus care. Approaches may be entirely novel or may build on existing evidence from the literature, but they must be presented with a rigorous rationale rather than as exploratory or purely descriptive work.

Program alignment also matters. Proposed projects must address the FY21 LRP Focus Area specific to the Transformative Vision Award, so applicants need to ensure their aims match the program’s stated priorities for that fiscal year. In addition, the proposed work must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the broader American public, which is a common requirement across Congressionally Directed Medical Research Programs (CDMRP) opportunities and reflects the DoD’s public-purpose mission.

The award explicitly allows human subjects research and clinical trials, which makes it suitable for studies that directly test interventions in people or in healthcare delivery settings. At the same time, animal research is not permitted under this announcement, so applicants need to design projects that do not rely on animal models for proof-of-concept or mechanistic testing within the scope of the funded work.

Another major requirement is authentic consumer advocate involvement. Applications must include one or more consumer advocates as integral members of the research team, with ongoing engagement throughout planning and implementation. The program expects advocates to help shape the research question, contribute to project design, participate in oversight, support recruitment strategies, and assist in evaluation and interpretation, rather than serving as symbolic advisors. The consumer advocate must be a lupus patient or caregiver who is active in a lupus advocacy organization, cannot be an employee of any participating organization, and should provide independent, objective input focused on patient impact. The advocate is also expected to have strong familiarity with current lupus issues and enough background or training to contribute meaningfully in a research environment.

The TVA also encourages collaboration through a Partnering Principal Investigator (PI) option. One PI serves as the Initiating PI and handles most submission-related administration, while up to two additional Partnering PIs can be named. The intent is for these PIs to make substantive contributions to the project’s development and core components (such as the project narrative and statement of work), not just to lend their names. If funded, each PI is named on an individual award within their organization, which can help formalize shared responsibility across institutions.

Awards under this announcement are issued as assistance agreements, meaning they are meant to support a public purpose rather than purchase a product or service for direct government use. Depending on how much active involvement the DoD anticipates during performance, the agreement may be structured as a grant (when no substantial agency involvement is expected) or a cooperative agreement (when substantial involvement is expected, such as collaboration or participation by the funding agency). The exact award type and start date are determined during negotiations.

In terms of funding, the anticipated total cost for the entire period of performance is capped at $2.5 million. The CDMRP expected to allocate about $2.5 million total to fund approximately one Transformative Vision Award under this FY21 opportunity, making it a highly competitive, single-award call where only the strongest and most compelling proposals are likely to be supported. The budget must be well matched to the work proposed and comply with the program’s funding restrictions. While the listing includes an “award ceiling” field of 0, the narrative guidance clearly establishes the practical maximum as $2.5 million total costs.

Key administrative details included an opportunity number of W81XWH-21-LRP-TVA, an original closing date of September 22, 2021, and an expectation that awards would be made no later than September 30, 2022. Funding availability is contingent on federal appropriations, the number and quality of submissions, and programmatic requirements. Funds anticipated for FY21 awards were expected to be FY21 dollars, with availability for use limited by the federal period of availability, noted here as expiring for use on September 30, 2027. Eligible applicants were listed as unrestricted, meaning the call was broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Lupus, Transformative Vision Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 26, 2021.
• Applicants must submit their applications by Sep 22, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 LRP TVA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: